Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Mangosteen Gel for NB-UVB-Induced Erythema
NCT07849842Phase 2Completed
- Sponsor
- Hasanuddin University
- Start
- Aug 2022
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Garcinia mangostana pericarp extract in erythema (6 arms), sponsored by Hasanuddin University. Primary endpoint: Change in Skin Redness (Chromameter a* Value) at Day 3. Started Aug 2022; status: completed.
02
Drugs
Garcinia mangostana pericarp extract
03
Conditions
erythema
Beyond the preview
Go deeper on NCT07849842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07849842.